These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 11798509

  • 1. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Goekce D, Diehl V, Zankovich R, Schaefer HE.
    J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
    [Abstract] [Full Text] [Related]

  • 2. Dynamics of CD34+ progenitor cells following allogeneic bone marrow transplantation in Ph1+CML--an immunohistochemical study on 113 patients with sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Beelen DW, Cicek G, Leder LD, Schaefer UW.
    J Hematother Stem Cell Res; 2002 Jun; 11(3):565-74. PubMed ID: 12183841
    [Abstract] [Full Text] [Related]

  • 3. CD34+ stem cells in chronic myeloproliferative disorders.
    Thiele J, Kvasnicka HM.
    Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
    [Abstract] [Full Text] [Related]

  • 4. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Schaefer HE.
    Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
    [Abstract] [Full Text] [Related]

  • 5. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Bundschuh S, Biermann T, Roessler G, Wasmus M, Diehl V, Zankovich R, Schaefer HE.
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [Abstract] [Full Text] [Related]

  • 6. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Cvetanovska G, Blum N, Schaefer HE.
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [Abstract] [Full Text] [Related]

  • 7. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N, Ma DD, Nevell DF, Arthur C.
    Hematopathol Mol Hematol; 1996 Aug; 10(4):213-22. PubMed ID: 9042664
    [Abstract] [Full Text] [Related]

  • 8. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Spohr M, Diehl V, Zankovich R, Niederle N, Leder LD.
    Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
    [Abstract] [Full Text] [Related]

  • 9. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Jan; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 10. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Flucke U, Spoer C, Paperno S, Leder LD, Schaefer UW.
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [Abstract] [Full Text] [Related]

  • 11. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [Abstract] [Full Text] [Related]

  • 12. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Leder LD, Schaefer HE.
    Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
    [Abstract] [Full Text] [Related]

  • 13. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R, Sala R, De Propris MS, Cordone I, de Fabritiis P.
    Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.
    Thiele J, Kvasnicka HM, Beelen DW, Leder LD, Schaefer UW.
    Histol Histopathol; 2001 Jan; 16(1):213-26. PubMed ID: 11193198
    [Abstract] [Full Text] [Related]

  • 15. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
    Soligo D, Delia D, Oriani A, Cattoretti G, Orazi A, Bertolli V, Quirici N, Deliliers GL.
    Leukemia; 1991 Dec; 5(12):1026-30. PubMed ID: 1723130
    [Abstract] [Full Text] [Related]

  • 16. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
    Hehlmann R, Berger U, Pfirrmann M, Hochhaus A, Metzgeroth G, Maywald O, Hasford J, Reiter A, Hossfeld DK, Kolb HJ, Löffler H, Pralle H, Queisser W, Griesshammer M, Nerl C, Kuse R, Tobler A, Eimermacher H, Tichelli A, Aul C, Wilhelm M, Fischer JT, Perker M, Scheid C, Schenk M, Weiss J, Meier CR, Kremers S, Labedzki L, Schmeiser T, Lohrmann HP, Heimpel H, German CML-Study Group.
    Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
    [Abstract] [Full Text] [Related]

  • 17. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA, Quiroga R, Sureda A, González JR, Moreno V, García J.
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [Abstract] [Full Text] [Related]

  • 18. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
    Bhatia R, Wayner EA, McGlave PB, Verfaillie CM.
    J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia.
    Thiele J, Kvasnicka HM.
    Leuk Lymphoma; 2001 Jul; 42(5):855-62. PubMed ID: 11697640
    [Abstract] [Full Text] [Related]

  • 20. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A, Rosas-Cabral A, Vela-Ojeda J, González JC, Mayani H.
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.